OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.
OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.
We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 7 days from acceptance to publication (median values for papers published in this journal in the first half of 2019, 1-2 days of FREE language polishing time is also included in this period).
Liver Tumors and Liver Transplantation
Submission Deadline: February 25, 2019(Open) Submit Now
Chirag S. Desai, MD
Associate Professor of Surgery, Surgical Director, Liver Transplant Program, Director, Chronic Pancreatitis and Autologous Islet Cell Transplant Program, Department of Surgery, University of North Carolina, Chapel Hill, 4024 Burnett Womack Building, Chapel Hill, NC 27599, USA
Research Interests: Liver transplantation; intestinal and multivisceral transplantation; liver and pancreatobiliary disorders; chronic pancreatitis; autologous islet cell transplantation
About This Topic
Indications for liver transplantation in adult and pediatric populations are increasing with improving outcomes. Due to increased awareness, improving diagnostic modalities and screening protocols hepatocellular carcinomas are identified early on in patients with chronic liver disease and increasing number of patients are listed and transplanted. Patients with hepatobalstoma, cholangiocarcioma and other malignancies in the setting of metabolic liver disease are more frequently transplanted then previously and the allocation system continues to evolve.
In this special issue on liver tumors and liver transplantation, submissions are invited related to this topic. Original research, quality and quantitative systematic analysis, review article, case reports pertaining to all liver tumors benign or malignant, in the adult or pediatric populations are welcome for submission. Topics involving allocation, waiting list management, pre-transplant down staging, tumor control therapies, surgical technique, molecular biology and pathology, outcomes and post-transplantation management are all eligible.
Title: Liver transplantation for intrahepatic Cholangiocarcinoma
Authors: R. Mark Ghobrial, Keri Lunsford
Title: HCC and BCLC – a single center experience
Authors: Gerd Otto
Title: Liver Transplantation or Resection for Treatment of Hepatocellular Carcinoma in Patients with Well-Compensated Cirrhosis: a Decision Analysis Model
Authors: Amanda B. Cooper, M.D., Stephen M. Downs, M.D. Nicholas J. Skill PhD. JD., Kubal, Chandrashekhar Avinash MD. PhD and Mary A. Maluccio, M.D., MPH
Sumail Bhogal, Matthew Minn, Pranay Krishnan, Reena C. Jha
Received: February 18, 2019; Published: November 18, 2019; doi:10.21926/obm.transplant.1904092
Amanda B. Cooper, Stephen M. Downs, Nicholas J Skill, Richard S. Mangus, Chandrashekhar A. Kubal, Mary A. Maluccio
Received: March 18, 2019; Published: May 13, 2019; doi:10.21926/obm.transplant.1902063